Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

Describe the antivirals that treat COVID-19
Evaluate the efficacy of antivirals that treat COVID-19
Discuss NIH recommendations for COVID-19 therapy
Discuss the new CDC COVID community levels
Employ recommended PPE guidance for COVID-19 from the CDC
Implement newest COVID-19n prevent research in hospitals
Describe current landscape of monoclonal antibodies for treatment of Covid-19
Discuss use of monoclonal antibody therapy for prevention of Covid-19
Determine role in therapy of monoclonal antibodies for patients with Covid-19

Abstract

Dr. Elise Martin, Dr. Erin McCreary, and Dr. Ghady Haidar, will discuss the most up-to-date epidemiologic trends in COVID-19 in our region, the most recent data regarding monoclonal antibodies, and data for antiviral therapeutics. Please join us for what promises to be a very interesting and informative hour.

Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements & Suggested Additional Reading:

Joint Accreditation Statement

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Suggested Additional Reading:

NIH Covid-19 guidelines: https://www.covid19treatmentguidelines.nih.gov/

IDSA Covid-19 guidelines: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/

SIDP Monoclonal antibody toolkit: https://sidp.org/COVID19-Monoclonal-Antibody-Toolkit-Guide

CDC Community levels: https://www.cdc.gov/coronavirus/2019-ncov/downloads/science/Scientific-Rationale-summary-COVID-19-Community-Levels.pdf

CDC Transmission Risk: https://covid.cdc.gov/covid-data-tracker/#datatracker-home

Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection — California, February–December 2021 https://www.cdc.gov/mmwr/volumes/71/wr/mm7106e1.htm

https://www.covid19treatmentguidelines.nih.gov

https://www.fda.gov/media/155050/download

Authors:

Elise Martin, MD, MS — Assistant Professor of Medicine, Division of Infectious Diseases, Associate Medical Director of Infection Prevention and Hospital Epidemiology, University of Pittsburgh School of Medicine
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Erin McCreary, PharmD — Clinical Assistant Professor of Medicine, Division of Infectious Diseases Director of Stewardship Innovation, Infectious Disease Connect University of Pittsburgh School of Medicine
Dr. McCreary disclosed she is on the Advisory Board for: AbbVie, Entasis, Cidara, Summit, Ferring, Merck, Shionogi.

Ghady Haidar, MD — Assistant Professor of Medicine, Division of Infectious Diseases Director, Research, Bone Marrow Transplant and Hematological Malignancy Infectious Diseases University of Pittsburgh School of Medicine
Dr. Haidar has received grant/research support funding from NIH, Karius, and Allovir.

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.